Massive Real-World TMS study aims to personalize depression treatment
NCT ID NCT06917339
First seen Apr 12, 2026 · Last updated May 07, 2026 · Updated 4 times
Summary
This study will analyze data from up to 156,000 people who received NeuroStar TMS for depression, OCD, or anxiety. Researchers want to learn how patient age, symptoms, and treatment settings affect results. The goal is to improve real-world use of TMS, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Neuronetics
RECRUITINGMalvern, Pennsylvania, 19355, United States
Contact
Conditions
Explore the condition pages connected to this study.